ALC

#375
Alcon Inc. Ordinary Shares
80.24 USD
+0.59%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
80.15
80.28
Годовой диапазон
71.55
99.20
Дневное изменение
+0.59%
Месячное изменение
+3.75%
6-месячное изменение
+8.26%
Годовое изменение
-12.66%
Предыдущее закрытие
79.77
Открыть
80.19
Bid
Ask
Минимум
80.15
High
80.28
Объем
212
Открыть полный график

Financials

Обзор Отчетность Статистика Дивиденды
Квартал Год
  • Market Capitalization 39.11 B
  • Employee 26 K
  • Founded N/A
  • CEO David J. Endicott
  • Website www.alcon.com
  • Headquarter Switzerland
  • FIGI UNKNOWN
  • Industry Technology
Общий доход
Чистая прибыль
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты

Alcon Inc

Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

Новости